Zilretta Approval Status
- FDA approved: No
- Brand name: Zilretta
- Generic name: triamcinolone acetonide
- Dosage form: Sustained-Release Intra-Articular Injection
- Company: Flexion Therapeutics, Inc.
- Treatment for: Osteoarthritis
Zilretta (triamcinolone acetonide) is a sustained-release corticosteroid polymer (PLGA) formulation intended to provide persistent concentrations of drug locally to amplify the magnitude and prolong the duration of pain relief in patients with osteoarthritis of the knee.
Development Status and FDA Approval Process for Zilretta
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.